272 related articles for article (PubMed ID: 33275754)
21. Somatic mutation panels: Time to clear their names.
Trottier AM; Cavalcante de Andrade Silva M; Li Z; Godley LA
Cancer Genet; 2019 Jun; 235-236():84-92. PubMed ID: 31101556
[TBL] [Abstract][Full Text] [Related]
22. [Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing].
Minucci A; Mazzuccato G; Marchetti C; Pietragalla A; Scambia G; Fagotti A; Urbani A
Mol Biol (Mosk); 2020; 54(4):688-698. PubMed ID: 32840490
[TBL] [Abstract][Full Text] [Related]
23. Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies.
Roloff GW; Shaw R; O'Connor TE; Hathaway F; Drazer MW
J Genet Couns; 2023 Jun; 32(3):744-749. PubMed ID: 36642751
[TBL] [Abstract][Full Text] [Related]
24. Discrimination of Germline
Hu Y; Alden RS; Odegaard JI; Fairclough SR; Chen R; Heng J; Feeney N; Nagy RJ; Shah J; Ulrich B; Gutierrez M; Lanman RB; Garber JE; Paweletz CP; Oxnard GR
Clin Cancer Res; 2017 Dec; 23(23):7351-7359. PubMed ID: 28947568
[No Abstract] [Full Text] [Related]
25. Germline and somatic drivers in inherited hematologic malignancies.
Zoller J; Trajanova D; Feurstein S
Front Oncol; 2023; 13():1205855. PubMed ID: 37904876
[TBL] [Abstract][Full Text] [Related]
26. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
27. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.
Matsui H; Hirata M
Int J Hematol; 2024 May; 119(5):552-563. PubMed ID: 38492200
[TBL] [Abstract][Full Text] [Related]
29.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
30. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
33. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
34. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.
Kluk MJ; Lindsley RC; Aster JC; Lindeman NI; Szeto D; Hall D; Kuo FC
J Mol Diagn; 2016 Jul; 18(4):507-15. PubMed ID: 27339098
[TBL] [Abstract][Full Text] [Related]
35. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
[TBL] [Abstract][Full Text] [Related]
36. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
[TBL] [Abstract][Full Text] [Related]
37. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
[TBL] [Abstract][Full Text] [Related]
39. Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
Cobaleda C; Godley LA; Nichols KE; Wlodarski MW; Sanchez-Garcia I
Cancer Discov; 2024 Mar; 14(3):396-405. PubMed ID: 38426560
[TBL] [Abstract][Full Text] [Related]
40. Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.
Roloff GW; Godley LA; Drazer MW
Genet Med; 2021 Jan; 23(1):211-214. PubMed ID: 32807974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]